A systematic review and pooled analysis of retrospective series of eribulin in metastatic breast cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference22 articles.
1. Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane;Kaufman;J Clin Oncol,2015
2. Eribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study;Cortes;Lancet,2011
3. Measuring inconsistency in meta-analyses;Higgins;Br Med J,2003
4. Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis;Neyeloff;BMC Res Notes,2012
5. Efficacité, tolérance, et coût de l'éribuline chez des patientes présentant un cancer du sein métastatique (in French);Paillard;Bull Cancer,2015
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative effectiveness and safety of eribulin in advanced or metastatic breast cancer: a systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2021-07
2. Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia;Asia-Pacific Journal of Clinical Oncology;2021-04-14
3. Vitamin D baseline levels at diagnosis of breast cancer: A systematic review and meta-analysis;Hematology/Oncology and Stem Cell Therapy;2021-03
4. Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States;Advances in Therapy;2021-01-24
5. A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma;European Journal of Obstetrics & Gynecology and Reproductive Biology;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3